A Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol CEP of the European Pharmacopoeia monograph is often referred to as a Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol Certificate of Suitability (COS). The purpose of a Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol to their clients by showing that a Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol CEP has been issued for it. The manufacturer submits a Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol CEP holder for the record. Additionally, the data presented in the Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol DMF.
A Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol suppliers with CEP (COS) on PharmaCompass.